Peptic Ulcer Disease DR.M.TALEBI.

Slides:



Advertisements
Similar presentations
Nursing Care of Patients WithUpper GI Disturbances
Advertisements

Drugs Used For Peptic Ulcer
Faculty of Allied Medical Sciences Histopathology and Cytology (MLHC-201)
Peptic Ulcer Disease Dr Maha Arafah. Objectives Upon completion of this lecture the students will : A] Understand the Pathophysiology of acute and chronic.
Management of Patients With Gastric and Duodenal Disorders
Peptic ulcer disease.
Peptic Ulcer & its Complications Prof. Dr. Faisal Ghani Siddiqui FCPS; MCPS-HPE; PGDip-bioethics.
Peptic Ulcer Disease Biol E /11/06. From: Current Diagnosis & Treatment in Gastroenterology - 2nd Ed. (2003)
PEPTIC ULCER disease (PUD) Dr. Gehan Mohamed Dr. Abdelaty Shawky.
Adult Medical-Surgical Nursing
Stomach and Duodenum AnatomyAnatomy PhysiologyPhysiology Operative proceduresOperative procedures Gastric disordersGastric disorders peptic ulcer diseases.
PEPTIC ULCER DISEASE Dr RAMBABU POPURI MD MD Asst. Professor Dept of General medicine Dept of General medicine.
D YSPEPSIA & P EPTIC U LCER By Dr. Zahoor 1. D YSPEPSIA What is Dyspepsia ?  Dyspepsia is used to describe number of upper abdominal symptoms such as.
Drugs for Peptic Ulcer Disease
1 Clinical Pharmacy Chapter Eight Peptic ulcer disease Rowa’ Al-Ramahi.
PEPTIC ULCER DISEASE NRS452 Norhaini Majid.
PUD & GORD Nik Sanyal. Overview How common is it + what are the risk factors? What are the symptoms and signs? Investigations Management Possible exam.
Peptic Ulcer Disease.
Made by: Belal Doudin Alaa Almor To: Dr. Adham Abu taha
Peptic Ulcer Disease. Peptic ulcer  refers to erosion of the mucosa lining any portion of the G.I. tract.  It is defined as : A circumscribed ulceration.
Stomach Ulcer(Peptic Ulcer) Stomach ulcer or peptic ulcer is the damage of the protective layer (lining) of stomach or gastrointestinal tract It may be.
Anti Ulceration and Anti Emetics Nur Irjawati S. Kawang, S.Si,
Gastric Acid Secretion 1. Acid synthesis – regulated by 3 transporters Lumen Plasma Parietal cell.
Pharmacology B Lin, I-Yao. A 43y/o male CEO of a multinational company experienced severe burning pain one and a half hour after a sumptuous lunch. This.
PEPTIC ULCER DISEASE Lykhatska G.V.. Peptic ulcer disease - Is recurrent disease, the main feature of which is the formation of defects (ulcers) of the.
PEPTIC ULCER. Ulcers are defined as a breach in the mucosa of the alimentary tract, which extends through the muscularis mucosa into the submucosa or.
D YSPEPSIA & P EPTIC U LCER By Dr. Zahoor 1. D YSPEPSIA What is Dyspepsia ?  Dyspepsia is used to describe number of upper abdominal symptoms such as.
Peptic Ulcer Disease Dr. Wael H. Mansy, MD Assistant Professor College of Pharmacy King Saud University.
H2 blockers and proton pump inhibitors By Prof. Hanan Hagar.
Gastrointestinal Pharmacology
Gastrointestinal Block Pathology lecture Nov 20, 2012 Dr. Maha Arafah Dr. Ahmed Al Humaidi Peptic Ulcer Disease.
Diagnosis of PUD.
PEPTIC ULCER DISEASE (PUD)
Chronic gastritis. Peptic ulcer of a stomach and duodenum. Ethiology
Gastroesophageal reflux Dr. Adnan Hamawandi Professor of pediatrics.
Peptic ulcer Presented by د. قصي العبيدي بورد ( دكتوراه ) جراحه عامه جامعة الكوفة - كلية طب.
Peptic Ulcer Disease Dr Maha Arafah.
Drugs in peptic ulcer (H 2 blockers and proton pump inhibitors) By Prof. Hanan Hagar.
GROUP D.  narrowing of the esophagus(distal) near the junction with the stomach (squamocolumnar jxn).  sequelae of gastroesophageal reflux– induced.
PEPTIC ULCER DISEASE (PUD) By Dr. Abdelaty Shawky Assistant professor of pathology 1.
Peptic ulcers are open sores in the mucosa of the lower oesophagus (esophageal ulcer), duodenum (dudenal ulcer ) and stomach (gastric ulcers). Caused.
Upper Gastrointestinal Disorders
Gastric and Duodenal Ulcer. 2 What is a Peptic Ulcer? It is a hole that forms in the mucosal wall of the stomach, in the pylorus (opening between stomach.
Functions of stomach Physiology Unit. Secretory and Digestive Functions of the Stomach The objective of the lecture is to discuss the functions of the.
Definition Peptic Ulcer
Treatment for Upper GI bleeding due to PUD. Goals Control upper GI bleeding Provide symptom relief Promote ulcer healing Prevent recurrence and other.
Department: Microbiology
GI For Rehabilitation.
Gastric and Duodenal Ulcer
Fatimah Abdullah 6th year MS, KFU
Peptic Ulcer Disease Thomas Rosenzweig, MD.
Chapter 33 Therapy of Gastrointestinal Disorders: Peptic Ulcers, GERD, and Vomiting.
Gastroesophageal Reflux Disease affecting the upper gastrointestinal tract. 10% of the population experience Heartburn is the cardinal symptom.
Peptic Ulcer Diseae.
DYSPEPSIA Dr.Azam teimouri Gastroenterologist
Peptic ulcer disease-2 Clinical presentation & investigations
Gastritis.
Dyspepsia & Peptic Ulcer
Drugs in peptic ulcer (H2 blockers and proton pump inhibitors)
Acute upper gastrointestinal Bleeding
Qassim J. odda Master in adult nursing
Dyspepsia & Peptic Ulcer
Lecture 11 Gastrointestinal Disorders Peptic Ulcer
Mucosal protective agents
GASTRITIS By : BILAL HUSSEIN.
Care of Patients with Stomach Disorders
Ulcerative Colitis Definition
Pathology and pathophsiolgy of peptic ulcer
Presentation transcript:

Peptic Ulcer Disease DR.M.TALEBI

Definition Peptic Ulcer A benign, localized defect in the mucosa of any part of the gastrointestinal tract which is exposed to acid and pepsin. Differentiate ulcer from erosion * Erosion is superficial mucosal defect. distinguish * Ulcer extend through the muscularis mucosa into the submucous or muscularis layer.

Occurs: Peptic Ulcer . Stomach (commonly) . Oesophagus (occasionally) . Duodenum ( commonly) . Stomach (commonly) . Oesophagus (occasionally) . Jejunum (occasionally) after surgical anastomosis to the stomach . Meckel’s diverticulum with ectopic gastric mucosa.

Epidemiological aspects Peptic ulcer * It occurs in up to 15% of the population at some time. * It is commoner in men. * The incidence increases with age. * The frequency of ulcer disease has marked temporal, geographical and racial variations. . Fallen over the last few decades – in most Western countries. . Increased incidence of ulcer complications

Peptic Ulcers: Gastric & Dudodenal

duodenal ulcer and gastric ulcer Peptic Ulcer duodenal ulcer and gastric ulcer

Epidemiological aspects Peptic ulcer * In most countries: . DU > GU . But in Japan, GU are more common. . DU, GU are more common in men than women. . But in Australia, women are more prone than men to develop GU. * The prevalence of both GU and DU . Increases with age . On average, patients with GU are ten years older than ones of DU . There is often a positive family history of peptic ulcer.

Causes Peptic ulcer The formation of peptic ulcer require the presence of increased aggressive factors ( including H.p, acid and pepsin, NSAID, alcohol, et.)and reduced defensive factors (including mucus/bicarbonate barrier, mucosa barrier, mucosal blood flux, prostaglandin, cellular metabolism) for its formation . In normal situation, the gastroduodenal mucosa can resist the aggressive factors and keep the mucosal integrity. But if there is an imbalance between aggressive factors and defensive factors, peptic ulcers would occur.

Causes Peptic ulcer * Common forms of peptic ulcer . Helicobacter pylori . NSAID (no-steroidal anti-inflammatory drugs) . Acid and pepsin . Stress * Uncommon specific forms of peptic ulcer . Heredity . Abnormal gastroduodenal locomotion .Other risk factors: Smoking Viral infection Diet

1.Helicobacter pylori (H.p) peptic ulcer the most important factors . approximately 70% of all GU . approximately 90% of all DU . Deracination of H.p would boost the healing of ulcer. How can H.p destroy local mucosal defective/repaired mechanism? 1. colonize the gastric mucosa. 1) urease 2) motility 2. increased acid secretion

peptic ulcer Why? 1)urease H.p can excrete urease, which produces ammonia from urea and raises the pH around the bacterium. So urease may be very important in the early colonization by creating a protective nonacid microenvironment shielding the organism from gastric juice. 2)motility The flagella can help H.p penetrate the mucosa layer and adhere to the gastric epithelial layer.

peptic ulcer 2. increased acid secretion First, the H.p infection would stimulate the local inflammatory reaction and immune reaction, that can reduce the quantity of D cells, which is a kind of secretion cells. It can secrete somatostatin that can inhibit the secretion of gastric juice. Secondly, the urea increases the pH level around the gastric mucosa, local gastric cells would secrete overfull acid to decrease the local pH. So the total secretion of acid is increased. Finally, the pH level is decreased, and the gastric or duodenal will suffer from overfull acid.

2.NSAID peptic ulcer After H.p infection, NSAID is the next important cause of altered mucosal defence leadimg to peptic ulceration in the presence of activated pepsin. Because NSAID can reduce the secretion of prostaglandin. Prostaglandin of series E can accelerate blood flux. Only enough blood supply can assure the normal protective effect. So it also play a major role in the maintenance of gastroduodenal defence mechanism. With the decreased defensive factor, the aggressive factor of acid is increased. So the ulceration occurs.

3.Acid and pepsin peptic ulcer Finally, the formation of peptic ulcers would rely on the digestive effect of acid and pepsin. Pepsin can decompose protein molecule, so H.p can invade mucus. The biologic activity of pepsin is depended on the pH value. When local pH value elevates to 4, pepsin can’t work well. So we often say that “No acid-peptic active, no ulcer.” Gastric acid is the keyword of the formation of peptic ulcer. Duodenal ulcer: increased Gastric ulcer: normal or decrease 4.stress High stress can stimulate vagus nerve, which can result in high secretion of acid .

6. Abnormal gastroduodenal locomotion 5. Heredity peptic ulcer Patients with peptic ulcer often have a family history of ulcer, particularly the patient with DU that develop below the age of 20 years. Some studies show that blood group O have a high risk to developing peptic ulcer, but the pathogenic significant of these finding is uncertain. 6. Abnormal gastroduodenal locomotion DU— quick gastric empty → overfull acid load food storage GU— movement obstruction → reflux digestive liquid 1.High acid secretion 2.Aggravating H.p infection 3.Increased bad effect of NSAID

7. Other risk factors: peptic ulcer 1) Smoking Smoking is an increased risk of peptic ulcer. Smoking can induce the formation of ulcer, affect the healing of ulcer, accelerate ulcer recurrence, and increased complication of ulceration. But the mechanism isn’t clear. Maybe it has a relation with acid secretion, bile reflux, and decreased prostaglandin. 2) Diet Tea, coffee, alcohol can result in high secretion of acid . 3) Viral infection

Pathology peptic ulcer 1.Location The localization of ulcers impacts pathophysiologic and clinical features. * DU,95% occuring in the duodenal bulb, anterior > posterior * GU, occurs anywhere in the stomach . Commonly GU occurs in the antrum near the angularis, just distal to the junction of the body and antral mucosa on the lesser curve. . Frequently proximal GU associated with active gastritis.

2.Quantity and size peptic ulcer QUANTITY: Usually single, although 5-20% may be multiple SHAPE: Round or elliptical SIZE: Usually diameter of ulcer is under 10mm,GU >DU. giant ulcer ---DU >2cm,GU>3cm 3.Character Benign ulcer: yellow or grayer fibrous exudation the bottom ----- clean the side ------ regular Malign ulcer: black fibrous exudation the bottom-----dirty the side ------atactic

Clinical features Peptic ulcer chronicity Common characters of peptic ulcer: periodicity rhythmicity * Symptoms: . Abdominal pain and discomfort (the most important symptoms) . Vomiting . Other: may be present, but of less clinical significance. – weight loss (GU or suspicion of GC) or gain (DU, eats to ease the pain) – nausea or anorexia – heartburn (common) – acid regurgitation – constipation

Clinical features peptic ulcer The history is unreliable for separating DU from GU . Abdominal pain or discomfort (very important) . Epigastric pain, often quite localized, is a frequent symptom. . Site – usually epigastric or the right or left of the midline. . DU – related to meals: being hungry, ½ to 3 hours after meals be relieved by food, milk, antacids. pain again , before next meal – often nocturnal: to wake the patient up at night . GU – pain is worse during the day – pain is precipitated by food relieved before next meal

Clinical features Peptic ulcer * Abdominal pain or discomfort (very important) . Persistent and severe pain should be considered complications of perforation or penetration into other organs. Initially: localized and the patient points a single finger to the site of the pain. As the pain becomes more severe: it becomes more diffuse and radiates to the back in the interscapular region. . Radiation - an index of the severity of pain - imply the penetration of the ulcer through the gastric or duodenal wall and invasion of other organs - pancreatic involvement Back

Clinical features Peptic ulcer Some questions will be noticed: * The majority of patients with abdominal pain will turn out not to have ulcer disease. * Many ulcer patients present with atypical pains or without pains. * If no special investigations, ulcer is impossible to be diagnosed. * Although DU patients have typically pain DU (e.g. hunger, after meals, better responses to medical treatment), ? the nature of the symptoms does not differentiate between GU

Clinical features Peptic ulcer *Vomiting: the vomiting with ulcer may have one of three causes. . Induced by the pain, especially GU. . Due to gastric outlet obstruction. . Self-induced, if patient’s vomiting eases the pain. Atypical ulcers . Giant ulcers . Pyloric channel ulcers . Postbulbar ulcers . Multiple ulcers . Peptic ulcers in the elderly . Silence peptic ulcers

Visible vessel gastric ulcer

Adherent clot

Flat pigment

Atypical ulcers Peptic ulcer Giant ulcer - DU > 2 cm, GU > 3 cm * Having a prolonged, typical history, or few previous symptoms. * No distinguishing pathophysiologic features. * Commonly it occurs in association with NSAID consumption. * Giant DU or prepyloric ulcers are associated with end-stage renal failure. * Character of giant DU: . On the posterior wall .It’s often associated with pain radiating to the back . Frequently it is complicated by bleeding, posterior penetration, pyloric obstruction * Giant GU: May carry an increased risk of harboring carcinoma

Atypical ulcers Peptic ulcer Pyloric channel ulcers Pain: It hasn’t typical periodical and rhythmicity abdominal pain. It occurs shortly after eating, It is poor alleviative by antacids * It has a high risk of vomiting, pyloric obstruction, penetration, and perforation. 图

Atypical ulcers Peptic ulcer Postbulbar ulcers * They were found in 10 % of a necropsy series。 * It beyonds the second portion of the duodenum。 * It has a higher rate of bleeding. * The symptoms are same with DU, but frequently pain is nocturnal and can radiate to back. * It has poorly response to the medical therapy. * Both endoscopy and radiography may miss diagnosis; only finding an area of narrowing or apparent spasm.

Atypical ulcers Peptic ulcer Multiple ulcers * Multiple, simultaneous ulcers occur in 2% to 20% of cases * Several features have been associated with multiple DU, which may be markers of an increased ulcer diathesis, including . cigarette smoking . deformity of the duodenal bulb . Zollinger-Ellison syndrome * Aspirin use is another cause of multiple ulcers * They are often clustered together

Atypical ulcers Peptic ulcer Peptic ulcer in elderly patients * The proportion of GU catches up with DU in the elderly. * Consumption NSAIDs increased the risk of complications * The manifestation of peptic ulcer is more likely to be silent. * The atypical character : atactic epigastric pain, nausea, vomiting, weight loss, anemia * Their ulcers tend to heal more slowly with ulcer therapy than younger counterparts. * We need differentiate it from gastric cancer.

Atypical ulcers Peptic ulcer Silence ulcer * 15-35% peptic ulcers may be silence ulcers. * Found only . by gastroscopy or barium meal . Complications of bleeding or perforation * It can take place in every age, but it is common in the elderly. * Consumption of aspirin may cause silence ulcer (30-40%).

Laboratory test peptic ulcer * [13C] or [14C] – urea breath test -------an oral urea load following H.pylori testing * endoscopic biopsy using rapid urease testing * endoscopic biopsy using hematoxylin-eosin or special Worthin-Starry silver staining * endoscopic biopsy using culture

Laboratory test Peptic ulcer Urea breath test (UBT) When the patient with H.p infection is administered oral radioactive [14C] – or nonradiactive [13C] urea, urease from H.p in the stomach metabolizes urea as follows: NH2*CONH2 + 3H2O → 2NH4OH + *CO2 The CO 2 (carbon dioxide) is eventually excreted in exhaled breath .An increase in labeled carbon dioxide which contain [14C] or [13C] in the breath identifies the presence of active H.p infection. These tests have consistently been found to have a sensitive and specificity exceeding 90%.

Laboratory test Peptic ulcer Rapid urease testing (RUT) As mentioned earlier, H.p produces large amounts of the enzyme urease, which lead to a pH change in the microenvironment of the organism. Biopsies obtained at the time of endoscopy are placed on the reaction stripe. If H.p is present, urease causes an increase in environment pH and a consequent color change in the test medium . Endoscopic biopsy using hematoxylin-eosin or special Worthin-Starry silver staining and culture are not sensitive or specificity, especially the culture which is slow and expensive, so they are not very useful in clinical.

Diagnosis peptic ulcer Analyse of the history is very important. If the patient has a typical epigastric pain, it’s a very important clue. But when the clinical feature isn’t typical, we should use some examine methods to diagnose. Upper gastrointestinal radiography * using double-contrast barium meal * Barium is within an ulcer Niche (round, oval, surrounded by smooth mound of edema) * Folds radiating to the crater * Attention:1.Shallow lesions < 0.5 cm are difficult to detect. 2.Active or acute gastrointestinal haemorrhage is the tabu of it.

Diagnosis peptic ulcer Endoscopy * Application: It can diagnose the benign or malignant ulcer, H.p . infection, upper gastrointestinal haemorrhage and obtain the biopsy specimens * Virtue: It’s a sensitive, specific, safe method and allowing direct inspection and biopsy. * DUs are nearly always benign * How to differentiate benign GU from gastric cancer? 1. multiple biopsy specimens are necessary 98% of cancers can be detected 2. the showing of them under the endoscopy are different. .

Differential diagnosis peptic ulcer Functional dyspepsia (indigestion) . It’s common in young women . . It doesn’t has structural or biochemical cause, the patient is normal or only has slight gastritis . .Clinical features:1. Nausea, belching, premature satiety, bloating and abdominal distension 2.Sometimes it likes ulcers. .Only endoscppy and radiography can differentiate ulcers from functional dyspepsia.

Differential diagnosis peptic ulcer Chronic cholecystitis and cholelithiasis . Pain – at the right upper quant – radiating to the right upper back – attacks induced by heavy or fat food – associated with fever or jaundice . Differential approach by – B type ultrasonography – Endoscopic retrograde cholangio-pancreatography (ERCP)

Differential diagnosis peptic ulcer Gastric carcinoma . Clinical features:1.Elderly patient is often with shorter presenting history 2.Complain of a continuous pain is increased by food. 3.In later stage ,the patient will have weight loss, early satiety, anorexia, nausea, vomiting . .It’s difficult for us to differentiate GU from gastric ulcers, the only useful way is endoscppy and radiography ,especially endoscppy, which can take biopsy . . Key way: Endoscopy (repeat, follow-up)

Summary of management of chronic peptic ulcer Consistent clinical symptoms Endoscopy No ulcer Ulcer Biopsy Exclude cancer ‘Non-ulcer Detect H. pylori dyspepsia’ H2-RA Heal ulcer Site protective drugs Cytoprotective agents Omeprazole Symptomatic Intermittent Maintenance treatment treatment treatment

Complications Peptic ulcer Hemorrhage Perforation Obstruction Canceration * Hemorrage is the most common complication * Perforation is the most lethal complication.

Complications Peptic ulcer Hemorrhage * Haemtemesis: Patients with haematemesis are more severe than ones with melaena alone. * Melaena: The black tarry melaenic stools distinguish from bright red rectal bleeding colonic or perianal lesions the greyish-greenish stool by using of iron supplements

Complications Peptic ulcer Management * Assessment of severity * Resuscitation * Diagnosis of the cause of haemorrhage * Observation * Specific treatment

Complications Peptic ulcer Assessment and Resuscitation * Marked tachycardia (pulse> 110) * Hypotension (blood pressure < 110 systolic) * Signs of hypovolaemic shock . Cold sweaty pallid skin . Weak rapid pulse . Irregular breathing . Dry mouth . Dilated pupils . Reduced flow of urine * Haemoglobin level below 90 mg/L If there are above presentations Immediate blood transfusion is indicated to expand the circulating volume, restore cardiac output, and blood pressure.

Complications Peptic ulcer Only when the haemodynamic status of the patient is stable, we should attempt to diagnose the cause of the bleeding. Causes * Duodenal ulcer - approximately 40% * Chronic gastric ulcer - 20% * Acute ulcers - 20% with analgesic ingestion (NSAID) * Oesophageal varices - 10% * Other 10% causes- . Mallory-Weiss lesions: Violent vomiting causes the tearing of the tissues around the junction of the gastric-oesophagus resulting in bleeding . Reflux oesophagitis . Gastric tumours Diagnosis Exact diagnosis using endoscopy is essential

Complications Peptic ulcer Observation * All patients should be in an intensive care ward of hospital * Noting any further haematemesis or melaena * Vital signs should be monitored at least hourly * Haemoglobin level estimated twice daily until the patient is stable * Central venous monitoring is indicated in elderly subjects * Continuous gastric aspiration is helpful in detecting continued or recurrent bleeding * Indications continued bleeding or rebleeding: - haematemesis - the aspiration of fresh blood from the stomach - significant changes in the pulse, blood pressure, central venous pressure - a marked drop in haemoglobin level

Complications Peptic ulcer Specific treatment for bleeding peptic ulcer * H2-receptor antagonists: increasing pH of stomach produces, if pH>6.0 * aggregation of platelet PPI(proton pump inhibitors): * coagulation of plsma induces Hematischesis * Endoscopy provides an opportunity to render treatment to reduce the chances of rebleeding: - Injection of a dilute solution of adrenalin causes vasoconstriction - Thermal coagulation can be achieved using a heater probe or NdYa laser * Surgery - over 60 years of age with chronic peptic ulcers, continued or recurrent bleeding. - severe bleeding and the signs of oligaemic shock regardless of their age, the presence of recurrent or continued bleeding.

Complications Peptic ulcer Gastric outlet obstruction DU 80% Prepyloric ulcer Pyloric channel ulcer Spasm or oedema fibrosis (medical treatment) (surgery) temporary permanent Stenosis Obstruction

Complications Peptic ulcer Gastric outlet obstruction Clinical presentation * Symptoms . Vomiting: stale food recognized which consumed > 5 hours . Alkalosis . Sodium and potassium depletion . Weight loss * Physical signs . Succussion splash and visible peristalsis (by distended stomach) * Diagnosis . endoscopy gastrointestinal . radiography

Complications Peptic ulcer Gastric outlet obstruction Treatment . Initial treatment includes fluid and electrolyte replacement . Normal saline supplemented with potassium is given intravenously . Gastric distension is alleviated by nasal gastric suction . H2-RA or Omeprazole are given intravenously . If obstruction due to severe fibrotic strictures and carcinoma require surgery

Complications Peptic ulcer Perforation The sudden pouring of acid content into the peritoneal cavity . severe abdominal pain . shock . vomiting . marked abdominal rigidity . absent bowel sound . air under the diaphragm shown by X-ray examination Treatment- operation should be performed as soon as possible after perforation

Complications Peptic ulcer Gastric carcinoma * 1-2% GU only * Warning . Long and chronic history of GU . Refractory GU . > 45 y . Ulcerated cancer can heal just only ulcer area but cancer; therefore, endoscopy+biopsy+follow up * Notice ! . Up to 5% of GU being benign on radiological and endoscopic criteria turn out to be malignant. . All GU should be biopsied. . All GU must follow up to healing.

Treatment peptic ulcer * Symptom relief * Initial healing * The refractory ulcer * Long – term treatment * Management of complications * Surgery Medical treatment . H2-RA (Histamine2 – receptor antagonits) . PPI (Proton pump inhibitors) . Protective drugs: Sulcralfate, Bismuth, Prostaglandins . Therapy of H.pylori

Treatment - Symptom relief peptic ulcer * Pain relieved by antacids or H2 – RA occasionally * Diet . No dietary restrictions are required . Milk – relieves ulcer pain , likely antacid – stimulates further acid secretion – excessive milk ingestion can theoretically be harmful . Smoking, NSAID, Aspirin, Alcohol, and Paracetamol should be avoided if possible * Stress or hard work have no an adverse influence on peptic ulcer * Modify exacerbating factors such as alcohol, NSAID, et al.

H.pylori eradicated peptic ulcer * Indications – first attacking ulcer – active or quiet ulcer – recurrent ulcer – ulcer with complications or without ones * Approach 1 Approach 2 PPI / CBS (480mg/d) PPI + CBS Clarithromycin 0.5-1.0 g/d if fail Clarithromycin or Amocicillin/Tetracycline or Amocicillin/Tetracycline 1-2 g/d or Metronidazole/furazolidone or Metronidazole/furazolidone 800mg/d H2 – RA may replaces PPI

Treatment - PPI peptic ulcer * PPI (Proton Pump Inhibitors) block H+ of GPC H+ - K+ - ATPase of the gastric parietal cell (GPC) X (hydrogen/potassium adenosine triphosphate enzyme) gastric lumen inhibit decrease H+ in exchange for K+ of the gastric parietal cell gastric acid * Omeprazole 20 mg p.o. Bid 7 d Lansoprazole 30 mg p.o. Bid 7 d Pantoprazole 40 mg p.o. Bid 7 d Rabeprazole 10 mg p.o. bid 7 d * Side effections . Headaches . Diarrhoea . Rashes . Pruritus . Dizziness . Others

Histamine2 – receptor antagonits peptic ulcer * Agents ① block Histamine-2 receptors on the gastric parietal cell ② inhibit Acid secretion * Including . Cimitidine 400 mg bid . Ranitidine 150 mg bid . Famotidine 20 mg bid . Nizatidine 150 mg bid * Adverse effects: main two categories Toxic effects (PPI) Side effects Hypochlorhydria . C-central nervous system reactions - bacterial overgrowth . immune modulation/hypersensitivity - hypergastrinemia . cardiac conduction abnormalities . idiosyncratic hepatic injury . headaches . thrombocytopenia . granulocytopenia . antiandrogenic

Treatment of gastric mucosa protection peptic ulcer Sucralfate . Stimulates angiogenesis . Prevents acute,chemically induced . Stimulates the formation of granulation tissue mucosal damage . Binds to the injured tissue . Without altering gastric acid or pepsin . Reduces access of pepsin and acid secretion . Suppresses H.pylori . Buffers acid . Inhibits acid secretion in DU with H. pylori CBS(colloidal bismuth subcitrate) Prostaglandins E and I . Treatment of H.pylori-positive PC ( Misoprostol or Cytotec) . Plus Ranitidine and Antibiotic can . Enhances mucosal defense enhance cure of H. pylori infection . Inhibits acid secretion . Blind to ulcer crater . Increases mucosal blood flow . Increases – mucosal prostglandin production . Increases mucus and bicarbonate – mucus and bicarbonate secretion ssecretion . Suppress the H. pylori

Causes of refractory and recurrent ulcer Persisting Helicobactor pylori infection Persisting Symptoms, No Ulcer . Poor compliance . Another diagnosis . Resistant organism . Irritable gut . Inadequate H. pylori regimen . Cancer, Crohn’s, other infections Persisting or recurrent ulcer, No H. pylori . False-negative H. pylori . Delayed healing . Continued or undiscovered NSAID use . Uncommon forms of ulcer Causes Delayed Healing . Dense fibrosis . Heavy smoking . Giant ulcer . Inadequate inhibition of acid secretion * H2-RA tolerance? or PPI resistance? . Hypersecretory states – gastrinoma – antral G cell hyperfuction – idiopathic hypersecretory DU

Pathology Peptic ulcer Chronic peptic ulcers * Usually single, although 5-20% may be multiple * Healing ulcers covered with . a single layer of undifferentiated epithelial cells . Followed by variable resolution of the underlying inflammation * Described four histologic zones by microscope: . A superficial layer of fibrin and exudate . Underlying zones of fibrinoid necrosis . Granulation tissue . Fibrosis

Location Peptic ulcer * Aspirin injury acute lesions: . multiple . shallow . minimal surrounding inflammation . fibrosis * Stress ulcer acute not generally surrounded by fibrosis * Ulcers in the gastric cardia or in a hiatal hernia pouch. * Jejunum, occur rarely. If they do, they follow . The creation of a surgical stoma . The occurrence of the Zollinger – Ellision syndrome

Causes Peptic ulcer * Common forms of peptic ulcer . Helicobacter pylori . NSAID (no-steroidal anti-inflammatory drugs) . Acid and pepsin . Stress * Uncommon specific forms of peptic ulcer . Heredity:Gastrinoma - inherited multiple endocrine neoplasia I - sporadic increased mast cells/basophils . Basophilic leukemias . Antral G cell hyperfuction/hyperplasia(H. pylori-induced and non-H.pylori) . Hypersecretory (non-H.pylori DU)

Laboratory evaluation Diagnosis of peptic ulcer . Complete blood cell count * Routine laboratory studies . Liver chemistries . Serum creatinine . Serum calcium * Special laboratory studies include Serum gastrin Serum salicylate reveal especially in recurrent ulcer unsuspected aspirin abuse . refractory require surgery .complicated refractory ulcer .recurrent post-surgical ulcers Serum pepsinogen I Acid secretion high low Hp associated antritis Atrophic gastritis GU-normal or low Gastrinoma Hyposecretory oxyntic mucosa DU- 30% high

Causes Peptic ulcer Viral infection - herpes simplex virus type I. - Cytomegalovirus * Duodenal obstruction/disruption (congenital annular pancreas) * Vascular insufficiency – associated perforations * Induced factors- . Radiation . Chemotherapy( hepatic artery infusions) * Rare genetic subtypes * Idiopathic

Differential diagnosis peptic ulcer Gastrinoma (Zollinger-Ellison syndrome) 2/3 malignancy Gastrin-secreting cells in the tumour (85% pancreas, 10-15% duodenal wall) secretion large amounts of gastrin gastric parietal cells . Recurrent, intractable, multiple ulcer, hypertrophy, hyperplasia Unusual site - 2nd part of duodenum secretion increased - jejunum large amounts of gastric acid . Endoscopy or barium meals- hypertrophy of gastric folds . Haemorrhage, perforation . Steatorrhoea . Damage of the small bowel mucosa Diagnosis Basal acid output (BAO) high Treatment Omeprazole Serum gastrin high Total gastrectomy